UK Markets open in 4 hrs 52 mins

The Worldwide Stem Cell Manufacturing Industry is Expected to Reach $18 Billion by 2026 at a CAGR of 9.4% from 2021

·4-min read

Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical (Autologous, Allogenic), Cell & Tissue Banking), End-user (Pharma & Biotech, Hospitals, Tissue Bank), and Region - Forecast to 2026" report has been added to's offering.

The Global Stem Cell Manufacturing Market is projected to reach USD 18 billion by 2026 from USD 11.5 billion in 2021, at a CAGR of 9.4% during the forecast period.

By product, the consumables segment accounted for the largest share of the Stem Cell Manufacturing market

The Stem Cell Manufacturing market by product is categorized into consumables, instruments, and stem cell lines. The consumables segment dominated the market in 2020. The large share of this segment can be attributed to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies.

Asia Pacific: The fastest-growing region in the Stem Cell Manufacturing market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to supportive regulatory framework and increasing public-private initiatives to encourage public awareness about stem cell-based treatments.

North America: the largest share of the Stem Cell Manufacturing market

North America accounted for the largest share of the Stem Cell Manufacturing market. Factors such as private funding and grants to support the clinical evaluation of stem cells for various applications are the major factors driving the market growth.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Stem Cell Manufacturing Market Overview
4.2 North America: Stem Cell Manufacturing Market Share, by Product & Country (2020)
4.3 Stem Cell Manufacturing Market Share, by End-user, 2020
4.4 Stem Cell Manufacturing Market, by Application, 2021 vs. 2026 (USD Million)
4.5 Stem Cell Manufacturing Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Growing Venture Capital Investments in Stem Cell Research Increasing Awareness About the Therapeutic Potency of Stem Cell Products Technological Advancements in Stem Cell Manufacturing Increasing Incidence of Cancer and Collaborative Efforts in Cancer Research
5.2.2 Restraints Significant Operational Costs Associated with Stem Cell Manufacturing and Banking
5.2.3 Opportunities Supportive Regulatory Framework Across Developing Countries Government Initiatives to Boost the Biotechnology and Biopharmaceutical Industries Increased Market Focus on Mesenchymal Stem Cells and Induced Pluripotent Stem Cells
5.2.4 Challenges Technical Limitations Associated with Manufacturing Scale-Up Socio-Ethical Concerns Related to the Use of Allogeneic and Human Embryonic Stem Cells
5.3 Impact of the COVID-19 Pandemic on the Stem Cell Manufacturing Market
5.3.1 Introduction
5.3.2 Supply Chain
5.3.3 Research & Development
5.3.4 Research Funding
5.4 Porter's Five Forces Analysis
5.4.1 Threat of New Entrants
5.4.2 Threat of Substitutes
5.4.3 Bargaining Power of Suppliers
5.4.4 Bargaining Power of Buyers
5.4.5 Degree of Competition
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Technology Analysis
5.7.1 Bioreactors
5.7.2 Cell Culture Media
5.7.3 Cell Imaging Systems
5.8 Ecosystem Analysis
5.9 Patent Analysis
5.10 Pricing Analysis
5.11 Regulatory Analysis
5.11.1 Regulatory Analysis for Stem Cell Manufacturing Products North America US Canada Europe
5.11.2 Regulatory Analysis for Stem Cell Therapy Products US European Union

6 Stem Cell Manufacturing Market, by Product

7 Stem Cell Manufacturing Market, by Application

8 Stem Cell Manufacturing Market, by End-user

9 Stem Cell Manufacturing Market, by Region

10 Competitive Landscape

11 Company Profiles
11.1 Key Market Players
11.1.1 Thermo Fisher Scientific
11.1.2 Merck Millipore
11.1.3 Lonza Group
11.1.4 Danaher Corporation
11.1.5 Sartorius AG
11.1.6 Becton, Dickinson and Company
11.1.7 Eppendorf AG
11.1.8 Corning Inc.
11.1.9 Bio-Rad Laboratories
11.1.10 Takara Bio Group
11.1.11 Fujifilm Holdings Corporation
11.1.12 Getinge AB
11.1.13 Terumo Corporation
11.1.14 Bio-Techne Corporation
11.1.15 Himedia Laboratories
11.2 Other Players
11.2.1 Stemcell Technologies Inc.
11.2.2 Miltenyi Biotec GmbH
11.2.3 Promocell
11.2.4 Anterogen Co. Ltd.
11.2.5 Cellgenix GmbH

12 Appendix

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting